ArticleFrontiers in molecular neuroscience2018

Drug Screening Identifies Sigma-1-Receptor as a Target for the Therapy of VWM Leukodystrophy.

Andrea Atzmon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.